Literature DB >> 6826350

Flunarizine, a calcium channel blocker, in the prophylactic treatment of migraine.

S Diamond, H Schenbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6826350     DOI： 10.1111/j.1526-4610.1983.hed2301039.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  6 in total

1.  Calcium channel antagonism by pizotifen.

Authors:  S J Peroutka; S B Banghart; G S Allen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-04       Impact factor: 10.154

2.  Comparative efficacy of cyclandelate versus flunarizine in the prophylactic treatment of migraine.

Authors:  G Nappi; G Sandrini; G Savoini; A Cavallini; C de Rysky; G Micieli
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

4.  [Drug treatment as migraine prophylaxis.].

Authors:  H C Diener; A Ziegler
Journal:  Schmerz       Date:  1989-12       Impact factor: 1.107

5.  [Therapy for migraine-the current state of the art and perspectives.].

Authors:  D Soyka
Journal:  Schmerz       Date:  1987-09       Impact factor: 1.107

6.  [Headache in children.].

Authors:  R Pothmann
Journal:  Schmerz       Date:  1990-03       Impact factor: 1.107
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.